Spray Drying For Improved Solubility

Source: Lonza

Spray drying has been used extensively in the pharmaceutical industry for a variety of particle engineering applications, including for the manufacture of bioavailability-enhancing formulations such as spray dried dispersions (SDDs) of drugs and polymers, more generally termed amorphous solid dispersions (ASDs). The process is continuous and readily scalable to accommodate the needs of a program, from early feasibility assessments through large-scale commercial launch. Spray dried powders can be readily converted to solid dosage forms for oral dosing or dosed as dry powders with a specified device for inhaled applications.

In a recent webinar, “Pharmaceutical Spray Drying: Sustainable Commercial Best Practices to Continuous Project-Focused Innovation,” experts from Lonza discussed the process that Lonza uses to develop a spray dried powder formulation and scale that formulation from early feasibility studies to commercial manufacturing. Following the webinar, presenters Travis Harrer, Manager, Process Engineering, and Jason Bertola, Head of Commercial Development North America, answered questions regarding Lonza’s processes and capabilities.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online